Abstract
Due to its high sensitivity, reproducibility and reliability, fura-2 is one of the most preferred tools to quantify Ca2+ levels. Recently, using fura-2/AM, some calcium channel blockers (CCBs) have been reported to have inhibitory effects on intracellular Ca2+ signaling even in nonexcitable cells that do not possess voltage-dependent Ca2+ channels (VDCC). Some CCBs are known to be photosensitive. Since photosensitive chemicals often have autofluorescent property, it is likely that CCBs with autofluorescence interfere with the fluorescent dye probes for Ca2+, which may cause misinterpretation of the results. The aim of this study was to clarify the characteristics of various CCBs on Ca2+ fluorescent probes and to identify proper fluorescent probes for each CCB to allow reliable Ca2+ measurement using endothelial cells (ECs), which possess no VDCC. Thapsigargin (TG, Ca2+-ATPase inhibitor on endoplasmic reticulum) increased fura-2 F340/F380 ratio from 0.75 ± 0.06 to 4.28 ± 0.32, suggesting the increase in cytosolic Ca2+ concentrations in ECs. Verapamil, nifedipine and nicardipine did not affect TG-induced increase in fura-2 F340/F380 ratio; however, amlodipine dose dependently inhibited the rise of fura-2 ratio by 24% at 100 nM, by 55% at 1 μM and by 82% at 10 μM, respectively, in ECs. In ex vivo experiments without cells, due to the autofluorescence of amlodipine excited by ultraviolet (UV light), amlodipine itself boosted the intensity of F380 much more than it did that of F340, which results in a decrease in F340/F380 ratio of fura-2 fluorescence. Rhod-2/AM, a fluorescent probe of which the excitation wavelength is out of the excitation spectrum of amlodipine, showed that amlodipine did not affect TG-induced intracellular Ca2+ increase in ECs. When the effect of amlodipine on intracellular Ca2+ concentration is assessed, fura-2 fluorospectrometry should not be used due to fluorescent interaction between amlodipine and fura-2, and using rhod-2 is strongly recommended.
Similar content being viewed by others
References
Batova S, DeWever J et al (2006) The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells. Cardiovasc Res 71(3):478–485
Berkels R, Taubert D et al (2004) Amlodipine increases endothelial nitric oxide by dual mechanisms. Pharmacology 70(1):39–45
Grynkiewicz G, Poenie M et al (1985) A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260(6):3440–3450
Li X, Ruan GR et al (2006) A novel stealth liposomal topotecan with amlodipine: apoptotic effect is associated with deletion of intracellular Ca2+ by amlodipine thus leading to an enhanced antitumor activity in leukemia. J Control Release 112(2):186–198
Stepien O, Zhang Y et al (2002) Dual mechanism of action of amlodipine in human vascular smooth muscle cells. J Hypertens 20(1):95–102
Watanabe H, Kuhne W et al (1991) Macromolecule permeability of coronary and aortic endothelial monolayers under energy depletion. Am J Physiol 260(4 Pt 2):H1344–H1352
Watanabe H, Takahashi R et al (1996) Inhibition of agonist-induced Ca2+ entry in endothelial cells by myosin light-chain kinase inhibitor. Biochem Biophys Res Commun 225(3):777–784
Yoshida J, Ishibashi T et al (2003) Antiproliferative effect of Ca2+ channel blockers on human epidermoid carcinoma A431 cells. Eur J Pharmacol 472:23–31
Zhou MS, Jaimes EA et al (2004) Inhibition of oxidative stress and improvement of endothelial function by amlodipine in angiotensin II-infused rats. Am J Hypertens 17(2):167–171
Acknowledgement
This study was supported by Ministry of Education, Culture and Science of Japan Grants-in-Aid 18390074 to H. Watanabe and 19590244 to K. Takeuchi.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Asai, M., Takeuchi, K., Uchida, S. et al. Misinterpretation of the effect of amlodipine on cytosolic calcium concentration with fura-2 fluorospectrometry. Naunyn-Schmied Arch Pharmacol 377, 423–427 (2008). https://doi.org/10.1007/s00210-007-0243-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-007-0243-x